User Fee Abolition and the Demand for Public Health Care

DOIhttp://doi.org/10.1111/saje.12146
AuthorSteven F. Koch
Date01 June 2017
Published date01 June 2017
USER FEE ABOLITION AND THE DEMAND
FOR PUBLIC HEALTH CARE
STEVEN F.KOCH*
Abstract
This research examines the effect of the abolition of user fees in South Africa, a policy imple-
mented in 1994 for uninsured children under the age of six and the elderly uninsured, as well as
pregnant and nursing mothers. The analysis focuses on the implementation of the policy and the
use of curative public healthcare services by children following strict and fuzzy regression discon-
tinuity designs. The estimates point to statistically insignif‌icant average and local average policy
effects, even though the policy appears to have been implemented reasonably effectively, albeit
imperfectly. In other words, the policy did not, on average, affect the use of curative public
healthcare, at least for those children who should have benef‌ited from the policy.
JEL Classif‌ication: I18, I12
Keywords: User fee abolition, regression discontinuity
1. INTRODUCTION
The imposition and abolition of health care user fees has been a feature of public health
care delivery in Africa for a number of decades. Spurred on by the goal of raising addi-
tional funds for health budgets and increasing the eff‌iciency of health care delivery, a
number of countries on the continent imposed user fees for public health services. How-
ever, experience with those fees was not particularly positive.
1
A number of African coun-
tries have, since, reversed tack, abolishing their user fee programs. The literature
examining these policies and changes has spawned a number of reviews, such as that by
Ridde and Morestin (2011) and Lagarde and Palmer (2008).
* Corresponding author: Professor and Head of Economics, Department of Economics, Uni-
versity of Pretoria, Pretoria, Republic of South Africa. Tel: 27-12-420-5285, Fax: 27-86-691-
2749. E-mail: steve.koch@up.ac.za
The author would like to thank Economic Research Southern Africa for their f‌inancial support.
The author would also like to thank Dane Kennedy and the Centre for High Performance
Computing (CHPC: www.chpc.ac.za) for their support. Comments from Jeffrey S. Racine,
Sara Markowitz, Gauthier Tshiswaka-Kashalala, Chitalu Chama-Chiliba, seminar participants
at the University of the Free State and Emory University, participants at the workshop on
Microeconometric Analysis of South African Data, and a number of anonymous reviewers
were instrumental in the improvement of this research. All remaining errors are the sole
responsibility of the author. This research is based on secondary, and publicly available data.
Ethics approval was received from the Faculty of Economic and Management Sciences
Research Ethics Committee.
1
In Kenya, Willis and Leighton (1995) f‌ind user fees associated with a 27% decrease in utilization
at provincial hospitals, a 46% decrease at district hospitals and a 33% decrease at health centres. In
Zambia, Blas and Limbambala (2001) f‌ind outpatient attendance reductions of 35%. Biritwum
(1994) f‌inds a 40% decrease in outpatient attendance in Ghana.
V
C2017 Economic Society of South Africa. doi: 10.1111/saje.12146
242
South African Journal of Economics Vol. 85:2 June 2017
South African Journal
of Economics
Largely, early studies focused on registrations at the clinic level, typically for one to
four clinics – see McCoy and Khosa (1996), Mwabu and Wang’ombe (1997), Wilkinson
et al. (1997), Wilkinson et al. (2001). Although these studies f‌ind relatively large
increases in registrations associated with user fee abolition, Lagarde and Palmer (2008)
worry that these studies cover too small a sample of clinics to be meaningful to policy-
makers, and that the studies are unlikely to have uncovered policy impacts. In South
Africa, the focus of this analysis, the most extensive sample is contained in Bayat and
Cleaton-Jones (2003), who consider 10 facilities. There are, however, more recent
facility-level studies in other countries that include a broader sample. For example,
Nabyonga et al. (2005) and Burnham et al. (2004) samples include six to ten health dis-
tricts in Uganda, respectively, while Masiye et al. (2008) and Chama-Chiliba and Koch
(2014) include data from most of the 72 districts in Zambia. With the exception of
Chama-Chiliba and Koch (2014), all of the aforementioned studies uncover large user
fee abolition associations, ranging from 17 to 54%; those increases are shown to coincide
with user fee abolition, but are not causal (Lagarde and Palmer, 2008). In addition to
increases in usage, Burnham et al. (2004), Walker and Gilson (2004) and Masiye et al.
(2008) uncover worker disgruntlement associated with the increased workload.
Although the literature suggests large and benef‌icial impacts are to be had, following
the reduction in healthcare access/use charges, Lagarde and Palmer’s (2008) review is
sceptical. Supported by their interrupted time series analysis, conceptually similar to
regression discontinuityn (RD), they argue that the published clinic-level literature,
including that in South Africa, leaves much to be desired. With respect to South Africa,
they are especially concerned by the willingness to imply national conclusions, based on
data from such a small set of clinics or hospitals, and they worry about possible concur-
rent changes that were also likely to have affected the impact.
2
One approach to addressing the causality limitations within the literature is through
randomised controlled trials (RCTs). For example, in the case of bednet provision, there
is strong evidence from Kenya that free distribution increased take-up (Cohen and
Dupas, 2010). Similarly, Miguel and Kremer (2004) f‌ind that the introduction of cost-
sharing for deworming drugs reduced take-up. More generally, Ashraf et al. (2010) pres-
ent convincing evidence that lower prices are more likely to lead to purchases, at least for
chlorine disinfectant, while post-acceptance discounts do not further inf‌luence purchase
decisions. However, large-scale RCTs of public health care user fee abolition have not
been undertaken. One large-scale analysis, McKelvey et al. (2012), suggests that there are
rather limited price effects associated with contraceptive use in Indonesia. Their analysis
is reasonably representative of “complete scale,” because the f‌inancial crisis impacted the
entire country, even if not uniformly. Although one would expect user fee abolition to
increase take-up, the user fee is not the only cost associated with accessing health facili-
ties. Furthermore, as implied by Burnham et al. (2004), Walker and Gilson (2004) and
Masiye et al. (2008) the health system may not be in a position to scale-up in response.
Therefore, the equilibrium impact of user fee abolition could be much smaller than pol-
icy makers expected, or as has been previously reported.
Because there are no RCTs allowing for the isolation of user fee abolition effects,
researchers have either assumed that user fee abolition was an exogenous policy shock
2
For example, Benatar (1997) highlights the construction of almost 100 new primary care clinics
that were opened by the end of 1996.
243South African Journal of Economics Vol. 85:2 June 2017
V
C2017 Economic Society of South Africa.

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT